HSV-1's contribution as a vector for gene therapy

被引：6
|
作者：
Epstein, Alberto L. [1 ]
机构：
[1] EG427 Pinpoint Gene Therapy, Paris, France
来源：
NATURE BIOTECHNOLOGY | 2022年 / 40卷 / 09期
关键词：
D O I：
10.1038/s41587-022-01449-1
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1316 / 1316
页数：1
相关论文
共 50 条
  • [1] HSV-1’s contribution as a vector for gene therapy
    Alberto L. Epstein
    Nature Biotechnology, 2022, 40 : 1316 - 1316
  • [2] Immobilized cobalt affinity purification for HSV-1 gene therapy vector.
    Jiang, CP
    Wechuck, JB
    Krisky, D
    Glorioso, JC
    Ataai, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U197 - U197
  • [3] Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1
    Q Wang
    J Guo
    W Jia
    Gene Therapy, 1997, 4 : 1300 - 1304
  • [4] Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1
    Wang, Q
    Guo, J
    Jia, W
    GENE THERAPY, 1997, 4 (12) : 1300 - 1304
  • [5] INFECTION OF CULTURED STRIATAL NEURONS WITH A DEFECTIVE HSV-1 VECTOR - IMPLICATIONS FOR GENE-THERAPY
    FREESE, A
    GELLER, A
    NUCLEIC ACIDS RESEARCH, 1991, 19 (25) : 7219 - 7223
  • [6] DEVELOPMENT OF AN EFFICIENT AND SAFE ONCOLYTIC HSV-1 VECTOR FOR GLIOBLASTOMA THERAPY
    Nakashima, Hiroshi
    Nguyen, Tran T.
    Shalkh, Imran
    Goins, William F.
    Chiocca, E. A.
    NEURO-ONCOLOGY, 2012, 14 : 36 - 37
  • [7] HSV-1 thymidine kinase gene therapy for peritoneal carcinomatosis
    Lechanteur, C
    Princen, F
    Lo Bue, S
    Detroz, B
    Fillet, G
    Gielen, J
    Bours, V
    Merville, MP
    GENE THERAPY OF CANCER, 1998, 451 : 115 - 119
  • [8] Fetal gene therapy via the cerebrospinal fluid using an HSV-1 amplicon cosmid based vector
    Patino, W
    Breakefield, XO
    Larsen, JW
    Kwok, A
    Andry, C
    Lebo, RV
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 583 - 583
  • [9] Quantitative kinetics of HSV-1-tk gene delivery to tumor cells using a recombinant HSV-1 vector:: Implications for imaging HSV-1 mediated gene transfer in vivo
    Jacobs, AH
    Tjuvajev, JG
    Joshi, A
    Joshi, R
    Herrlinger, U
    Balatoni, J
    Finn, R
    Breakefield, XO
    Blasberg, RG
    NEUROLOGY, 1998, 50 (04) : A273 - A273
  • [10] HSV-1 amplicon peptide display vector
    Spear, MA
    Schuback, D
    Miyata, K
    Grandi, P
    Sun, F
    Yoo, L
    Nguyen, A
    Brandt, CR
    Breakefield, XO
    JOURNAL OF VIROLOGICAL METHODS, 2003, 107 (01) : 71 - 79
12345